besthealtharticle.com
Home »
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of vaccine would potentially be much easier to produce and would not need refrigeration, report researchers at Boston Children's Hospital in the November 2 issue of […]
The unprecedented health crisis caused by the coronavirus disease 2019 (COVID-19) pandemic has affected over 247 million individuals to date. Monoclonal antibodies (mAbs) that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein have been found to have good neutralization efficacy in the treatment of Ebola virus, SARS, middle east respiratory syndrome (MERS), […]
A unique type of tiny antibody produced by llamas could provide a new frontline treatment against COVID-19 that can be taken by patients as a simple nasal spray. Research led by scientists at the Rosalind Franklin Institute has shown that nanobodies—a smaller, simple form of antibody generated by llamas and camels—can effectively target the SARS-CoV-2 […]
Scientists worldwide believe that vaccination is the most effective measure to contain the ongoing coronavirus disease 2019 (COVID-19) pandemic. This pandemic has been caused by an RNA virus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is extremely infectious and belongs to the Coronaviridae family of enveloped, positive-strand RNA viruses. Background Several COVID-19 vaccines have […]
China, August 16, 2021 – Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047. A total of 17 million shares were […]
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic. Researchers from the University of Padua and Imperial College London tested more than 85 percent of the 3,000 residents of Vo’, Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and […]
Researchers in the United States have conducted a study showing that the humoral (antibody) immunity induced by vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – varies significantly among immunocompromised individuals. The findings come from an interim analysis of an ongoing observational, prospective cohort analysis […]
FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the “THE ANTIBODY SERIES” – a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery. The conference is being launched in Porto, Portugal, celebrating FairJourney Biologics’ inauguration of […]
Researchers in the UK have reported on the relationship between humoral (antibody) responses and protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following immunization with AstraZeneca’s ChAdOx1 vaccine. The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that continues to pose a threat to global public health […]
insights from industryMark BumillerTechnology Manager Entegris In this interview, Mark Bumiller, Technology Manager at Entegris talks to News Medical Life Sciences about the role nanoparticles can play in drug delivery. Could you give our readers some background on Entegris? With over 50 years of experience, Entegris is a global leader in Advanced Materials Science and […]